TI-001 (Intranasal Oxytocin) for Treatment of High Frequency Episodic Migraine and Chronic Migraine

NCT01839149 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

240

Enrollment

INDUSTRY

Sponsor class

Conditions

High Frequency Episodic Migraine and Chronic Migraine

Interventions

DRUG: TI-001
DRUG: Placebo

Sponsor

Trigemina, Inc